SGD Pharma
SGD Pharma is a global manufacturer of pharmaceutical glass primary packaging — Type I, II and III vials, ampoules, infusion bottles, nasal bottles and droppers — operating 10 ISO 15378-certified plants in Europe and Asia and serving injectable, infusion, oral and nasal drug producers worldwide through direct sales and an extensive distributor network.
- Company typePrivate
- Founded1917
- HeadquartersHyderabad, India
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What SGD Pharma does
SGD Pharma is a global manufacturer of glass primary packaging for the pharmaceutical industry, producing Type I, II and III borosilicate and soda-lime vials, ampoules, infusion bottles, syringes, droppers and nasal bottles in both molded and tubular formats. The company operates 10 ISO 15378-certified manufacturing plants across France, Germany, India, China and Italy, with daily output exceeding 8 million units (more than 2 billion vials annually), and supports customers with proprietary value-added treatments including SEALIAN internal siliconization, Sterinity ready-to-use sterile vials, Velocity Vials (with Corning), IDENCY next-generation vials, EasyLyo lyophilization vials, Clareo Type II vials, U-Save nasal bottles, and PROSEAL+ thermoseal pre-treatment. Its commercial model is a direct enterprise sales motion through 9 sales offices and a channel network of approximately 90 distributors and partners, supported by on-site customer audits, regulatory affairs support and a laboratory testing service; pricing is quote-based under multi-year contracts with pharmaceutical manufacturers.
The business serves injectable/parenteral, infusion, oral medication, nasal delivery, beauty and consumer healthcare segments. SGD Pharma is privately held under PAI Partners as lead sponsor with China Jianyin Investment (JIC) as a significant minority shareholder following a separation from the legacy SGD Group perfumery entity; the company has accelerated capacity and capability expansion since 2017, including the Saint-Quentin-la-Motte molded glass center of excellence (€65M+), the Zhanjiang furnace rebuild (+11% capacity), the Cogent Glass tubular conversion platform in India, the 2023 Corning joint venture for a Telangana glass tubing facility, and the Q4 2025 acquisition of Alphial for additional Italian tubular capacity. Environmentally, the company is positioned in the top 1% of EcoVadis-rated firms globally (Platinum, 90/100 in 2025), carries CDP Climate A, and has SBTi-validated targets to reduce emissions 42% by 2030 and 65% by 2040 versus 2022.
SGD Pharma firmographics
Firmographics- Name
- SGD Pharma
- Legal name
- SGD S.A.
- Website
- https://sgd-pharma.com
- Company type
- Private
- Founded year
- 1917
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- SGD Pharma is a global manufacturer of pharmaceutical glass primary packaging — Type I, II and III vials, ampoules, infusion bottles, nasal bottles and droppers — operating 10 ISO 15378-certified plants in Europe and Asia and serving injectable, infusion, oral and nasal drug producers worldwide through direct sales and an extensive distributor network.
- Ownership category
- akta.pro rank
SGD Pharma industry classification
Industry- Product category
- Pharmaceutical Glass Packaging
- NAICS
- Glass Container Manufacturing (327213), Glass and Glass Product Manufacturing (32721)
- SIC
- Glass Containers (3221), Glass & Glassware, Pressed Or Blown (3220)
- akta.pro primary industry
- Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes) (IMALAEAB)
- akta.pro secondary industries
- Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE)
Keywords
Where SGD Pharma is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices10 records
Markets served
SGD Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Infrastructure, Personnel, Technology or R&D
Revenue model
- Pharmaceutical Glass Packaging Sales: Manufacturing and selling pharmaceutical glass primary packaging including vials, bottles, ampoules in Type I, II, and III glass for injectable, infusion, and oral drug delivery applications. Revenue generated from direct sales to pharmaceutical manufacturers worldwide.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom quotation-based pricing for pharmaceutical glass packaging |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
SGD Pharma product offering
Product offeringCore offering
SGD Pharma manufactures glass primary packaging for the pharmaceutical industry, producing Type I, II, and III borosilicate and soda-lime glass vials, bottles, ampoules, dropper bottles, aerosols, and specialty containers. The company serves injectable, infusion, oral, nasal, beauty, and healthcare applications with value-added treatments such as internal siliconization, plastic coating, and sterile ready-to-use formats.
Product overview
SGD Pharma is a global leader in glass pharmaceutical primary packaging, offering a comprehensive portfolio of products and services for the pharmaceutical, healthcare, and beauty industries. The company's core offerings include Type I, II, and III glass vials (both molded and tubular formats), ampoules, infusion bottles, and oral liquid containers. Key branded products include Sterinity (sterile RTU vials), Idency (next-generation vials), EasyLyo (lyophilization vials), Clareo (premium Type II vials), and Velocity Vials (with Corning technology). The company provides value-added services including SEALIAN internal siliconization, PROSEAL+ pre-treated glass for thermosealing, plastic coating, and LabServices. SGD Pharma operates 10 manufacturing plants across Europe and Asia, with recent expansion through the Alphial acquisition (Q4 2025) strengthening tubular glass capabilities. The company serves diverse markets including injectables, infusions, oral medications, nasal delivery, and beauty/personal care packaging.
Differentiator
Problem solved
Functional benefit
Brands
- Embelia: Full service primary packaging for beauty and health sectors (formerly VG Emballage)
Products and services
- Injectable Vials Type I Type I borosilicate glass injectable vials available in both molded and tubular glass formats, designed for parenteral pharmaceutical applications requiring high chemical resistance.
- Sterinity High-quality depyrogenated sterile empty vials designed for aseptic filling in pharmaceutical manufacturing as part of the ready-to-use (RTU) vial portfolio.
- Idency Next-generation molded glass vials offering enhanced chemical durability and performance characteristics for injectable drug packaging.
- EasyLyo Vials specifically designed for lyophilization (freeze-drying) applications in pharmaceutical manufacturing.
- Clareo Premium Type II glass vials for injectable drug solutions. Shortlisted as finalist for CPhI Pharma Awards 2018 in the Packaging category.
- Velocity Vials
Quantifiable outcome
- EcoVadis score of 90/100 earning Platinum medal for second consecutive year - top 1% globally
- +3 more outcomes
Companies that use SGD Pharma
Customer profileNamed customers2 records
Segments6 records
Ideal customer profiles3 records
SGD Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
SGD Pharma partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- AlphialcoreSGD Pharma acquired Alphial from Entangled Capital and Capital Dynamics in Q4 2025, expanding tubular glass capabilities with Italian-based production sites, strengthening European footprint.
- Corning IncorporatedflagshipJoint venture for glass tubing facility in Telangana, India. Combines Corning's Velocity Vial glass-coating technology with SGD Pharma's vial-converting expertise. Phase one for Velocity Vials production started March 2024, tubing production began late 2025. Co-locates tubing production and vial converting to improve product quality, filling-line productivity, and supply chain resilience.
- Ompi (Stevanato Group)corePartnership with Ompi Ez-fill platform to offer sterile and depyrogenated vials to parenteral market. SGD Pharma became first molded glass supplier to offer RTU vials through Ompi platform.
Scale indicators7 records
Recent moves11 records
Expansion highlights7 records
SGD Pharma competitors and assessment
Company assessmentDirect peers
- Bormioli Pharma: Bormioli Pharma is an Italian manufacturer of pharmaceutical glass and plastic packaging, including vials, bottles, and containers for injectables and oral medications. The company is a direct competitor to SGD Pharma in European pharmaceutical glass packaging markets, with similar product offerings in Type I, II, and III glass vials.
- Schott Pharma: Schott Pharma is the leading global manufacturer of pharmaceutical glass packaging, including vials, ampoules, syringes, and cartridges made from Type I borosilicate glass. They are the most direct competitor to SGD Pharma, serving the same injectable, infusion, and parenteral pharmaceutical markets with comparable product portfolios and regulatory certifications.
- Nipro Corporation: Nipro Corporation is a Japanese manufacturer of pharmaceutical glass packaging, including vials, ampoules, syringes, and cartridges, with global production and sales capabilities. The company competes directly with SGD Pharma in pharmaceutical glass primary packaging, particularly in the Asian and European markets.
- Gerresheimer AG: Gerresheimer is a European-based manufacturer of pharmaceutical packaging made from glass and plastic, including vials, ampoules, syringes, and containers for injectable drugs. The company competes directly with SGD Pharma across multiple product categories including pharmaceutical glass vials, with comparable global manufacturing footprint and customer base in pharma.
- Stevanato Group: Stevanato Group is a global provider of pharmaceutical containment solutions, including glass vials, syringes, and its EZ-fill ready-to-use platform. SGD Pharma has a partnership with Stevanato's Ompi EZ-fill platform but is also a direct competitor in molded and tubular glass vials for injectables, particularly as both companies expand in RTU sterile formats.
Regional players
- Verallia: Verallia is a European leader in glass packaging for beverages and food, with limited but growing presence in pharmaceutical glass. While primarily focused on food and beverage glass, Verallia competes with SGD Pharma in glass manufacturing capabilities and could expand into pharmaceutical-grade products, particularly in European markets.
Broad incumbents
- West Pharmaceutical Services: West Pharmaceutical Services is a global leader in injectable drug containment and delivery, including elastomer components, stoppers, seals, syringes, and integrated systems. While West's primary focus is elastomers and delivery systems rather than glass, they compete with SGD Pharma in the broader pharmaceutical primary packaging market, particularly for injectable drugs.
Emerging players
- Corning Incorporated (Pharma): Corning is the primary supplier of pharmaceutical glass tubing and a strategic JV partner of SGD Pharma for Velocity Vials in India. While Corning provides tubing to multiple vial converters, its proprietary Velocity Vial coating technology and direct entry into converted vials via the SGD JV creates partial overlap with SGD Pharma's product portfolio in specific high-end injectable applications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
SGD Pharma compliance and trust
Trust signalCompliance16 records
SGD Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
SGD Pharma leadership team
Management profileNumber of profiles
Profiles4 records
SGD Pharma subsidiaries and ownership
Company hierarchySubsidiaries2 records
SGD Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SGD Pharma M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SGD Pharma
What does SGD Pharma do?
SGD Pharma manufactures glass primary packaging for the pharmaceutical industry, producing Type I, II, and III borosilicate and soda-lime glass vials, bottles, ampoules, dropper bottles, aerosols, and specialty containers. The company serves injectable, infusion, oral, nasal, beauty, and healthcare applications with value-added treatments such as internal siliconization, plastic coating, and sterile ready-to-use formats.
Is SGD Pharma a public or private company?
SGD Pharma is a private company. It is classified as private equity controlled and is currently operating.
When was SGD Pharma founded?
SGD Pharma was founded in 1917. It employs 501 to 1,000 people.
Where is SGD Pharma based?
SGD Pharma is headquartered in Hyderabad, India, in the Asia region.
How does SGD Pharma make money?
One revenue line is on record: pharmaceutical Glass Packaging Sales.
Who are SGD Pharma's main competitors?
Direct peers on record are Bormioli Pharma, Schott Pharma, Nipro Corporation, Gerresheimer AG and Stevanato Group. Verallia is listed as a regional player. West Pharmaceutical Services is listed as a broad incumbent. Corning Incorporated (Pharma) is listed as an emerging player.
Does SGD Pharma have an API?
No public API is recorded for SGD Pharma.
What industry is SGD Pharma in?
SGD Pharma's product category is Pharmaceutical Glass Packaging. Its primary akta.pro industry code is IMALAEAB, Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes), with a secondary code of IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules). Its NAICS code is 327213 and its SIC code is 3221.